Animal models to evaluate anti‐atherosclerotic drugs

By  

Fundamental & Clinical Pharmacology, Vol. 29, Iss. 4, 2015-08 ,pp. : 329-340

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential

By Crooke Almudena   Huete-Toral Fernando   Martínez-Águila Alejandro   Colligris Basilio   Pintor Jesus  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 10, 2012-10 ,pp. : 989-1001

Informa Healthcare

Access to resources Recommend Favorite

Impulse control and serotonergic drugs: commonalities and differences in animal models

By De Vry J.   Schreiber R.   de Beun R.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 177-178

Elsevier

Access to resources Recommend Favorite

Influence of the Novelty-Seeking Endophenotype on the Rewarding Effects of Psychostimulant Drugs in Animal Models

By  

Current Neuropharmacology, Vol. 14, Iss. 1, 2016-01 ,pp. : 87-100

Bentham Science Publishers

Access to resources Recommend Favorite

Bile Acid Reabsorption Inhibitors (BARI): Novel Hypolipidemic Drugs

By  

Current Medicinal Chemistry, Vol. 13, Iss. 9, 2006-04 ,pp. : 997-1016

Bentham Science Publishers

Access to resources Recommend Favorite